Pressemitteilung, 08.09.2009
APEPTICO presents its lead product AP301
at the Annual Congress of the European Respiratory Society in Vienna, Austria
[mehr]


Pressemitteilung, 11.08.2009
Adriacell Closing of A Round Financing
11th August 2009, Trieste – Italy: Adriacell, a preclinical, oncology-focused biotech company
announced the completion of A round financing.
[mehr]


Pressemitteilung, 20.07.2009
APEPTICO granted Orphan Medicinal Product Designation
by EMEA for lead product AP301
[mehr]


Pressemitteilung, 09.06.2009
APEPTICO GmbH erhält Preis anlässlich der Verleihung des
“Venture Capital & Private Equity Award Österreichs“
[mehr]


Pressemitteilung, 29.05.2009
APEPTICO GmbH closes seed financing round
[mehr]

23.03.2009
ugichem to enter into research collaboration with Santhera Pharmaceuticals to evaluate and apply ugichem’s
oligonucleotide platform technology in the field of rare neuromuscular diseases
[mehr]

Pressemitteilung, 27.10.2008
Starke Wachstumsaussichten für den Nanomedizin-Spezialisten
[mehr]